Drug(薬物リスト) DrugBank | All Description Patterns💬 Info on mouse-over

17 / 17,542 descriptions

No. 薬物名(臨床試験情報から抽出) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY
On map, Yellow: Drug target genes
指定難病告示番号
1 Extended-release oxycodone Oxycodone 3件: D03783, D05312, D05462 💬 3件: OPRD1, OPRK1, OPRM1 💬 5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 1件: 13 💬
2 Oxycodone Oxycodone 3件: D03783, D05312, D05462 💬 3件: OPRD1, OPRK1, OPRM1 💬 5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 7件:  6 , 13, 46, 70, 226, 231, 298 💬
3 Oxycodone by patient-controlled analgesia (pca) Oxycodone 3件: D03783, D05312, D05462 💬 3件: OPRD1, OPRK1, OPRM1 💬 5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 1件: 46 💬
4 Oxycodone depot ”sandoz”, depot tablets Oxycodone 3件: D03783, D05312, D05462 💬 3件: OPRD1, OPRK1, OPRM1 💬 5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 1件: 298 💬
5 Oxycodone hydrochloride Oxycodone 3件: D03783, D05312, D05462 💬 3件: OPRD1, OPRK1, OPRM1 💬 5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 4件:  6 , 70, 226, 298 💬
6 Oxycodone naloxone prolonged release tablets Naloxone 5件: D01340, D03783, D05312, D05462, D08249 💬 3件: OPRD1, OPRK1, OPRM1 💬 5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 1件: 226 💬
7 Oxycodone orion Oxycodone 3件: D03783, D05312, D05462 💬 3件: OPRD1, OPRK1, OPRM1 💬 5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 1件: 70 💬
8 Oxycodone/acetaminophen Acetaminophen 4件: D00217, D03783, D05312, D05462 💬 5件: OPRD1, OPRK1, OPRM1, PTGS1, PTGS2 💬 28件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Estrogen signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, Morphine addiction, NF-kappa B signaling pathway, Neuroactive ligand-receptor interaction, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, Sphingolipid signaling pathway, TNF signaling pathway, VEGF signaling pathway, cGMP-PKG signaling pathway 1件: 231 💬
9 Oxycodone/naloxone prolonged release t Naloxone 5件: D01340, D03783, D05312, D05462, D08249 💬 3件: OPRD1, OPRK1, OPRM1 💬 5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 1件: 226 💬
10 Oxycodone/naloxone prolonged release tablets Naloxone 5件: D01340, D03783, D05312, D05462, D08249 💬 3件: OPRD1, OPRK1, OPRM1 💬 5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 1件:  6  💬
11 Oxycodone/naloxone prolonged release tablets 10 mg /5 mg Naloxone 5件: D01340, D03783, D05312, D05462, D08249 💬 3件: OPRD1, OPRK1, OPRM1 💬 5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 1件:  6  💬
12 Oxycodone/naloxone prolonged release tablets 10/5 mg Naloxone 5件: D01340, D03783, D05312, D05462, D08249 💬 3件: OPRD1, OPRK1, OPRM1 💬 5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 1件: 226 💬
13 Oxycodone/naloxone prolonged release tablets 20 mg /10 mg Naloxone 5件: D01340, D03783, D05312, D05462, D08249 💬 3件: OPRD1, OPRK1, OPRM1 💬 5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 1件:  6  💬
14 Oxycodone/naloxone prolonged release tablets 20/10 mg Naloxone 5件: D01340, D03783, D05312, D05462, D08249 💬 3件: OPRD1, OPRK1, OPRM1 💬 5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 1件: 226 💬
15 Oxycodone/naloxone prolonged release tablets 5 mg /2.5 mg Naloxone 5件: D01340, D03783, D05312, D05462, D08249 💬 3件: OPRD1, OPRK1, OPRM1 💬 5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 1件:  6  💬
16 Oxycodone/naloxone prolonged release tablets 5/2.5 mg Naloxone 5件: D01340, D03783, D05312, D05462, D08249 💬 3件: OPRD1, OPRK1, OPRM1 💬 5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 1件: 226 💬
17 Pr oxycodone Oxycodone 3件: D03783, D05312, D05462 💬 3件: OPRD1, OPRK1, OPRM1 💬 5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 1件:  6  💬